Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1989 | 12-1988 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 477 | N/A |
| Marketable Securities | 1,745 | N/A |
| Receivables | 4,203 | N/A |
| Inventories | 3,122 | N/A |
| Other current assets | 1,209 | 0 |
| TOTAL | $10,756 | $N/A |
| Non-Current Assets | ||
| PPE Net | 7,202 | N/A |
| Other Non-Current Assets | 895 | 0 |
| TOTAL | $8,097 | $N/A |
| Total Assets | $18,852 | $N/A |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 397 | N/A |
| Accounts payable and accrued liabilities | 3,053 | 0 |
| TOTAL | $4,065 | $N/A |
| Non-Current Liabilities | ||
| Long Term Debt | 2,465 | N/A |
| TOTAL | $3,029 | $N/A |
| Total Liabilities | $7,094 | $N/A |
| Shareholders' Equity | ||
| Common Shares | 40 | N/A |
| Retained earnings | 2,602 | N/A |
| Other shareholders' equity | -350 | 0 |
| TOTAL | $11,758 | $N/A |
| Total Liabilities And Equity | $18,852 | $0 |